For U.S. tax purposes, a company must comply with certain tax and transfer pricing considerations when structuring intercompany debt transactions. Considerations include application of the arm's length...
Cities impacted by commercial real estate vacancies are seeing more commercial buildings converted to residential units. Such conversions may be promising, with lucrative returns for developers and owners...
Artificial Intelligence (AI) is all over the news, your podcasts, and even CLE courses. But should you also be addressing AI with specific provisions in your acquisition agreements? Whether your client...
Do you need to learn about the growing trend in some states of relaxing or even eliminating the legal standard in workplace harassment cases? Read our article on lowering the bar for workplace harassment...
Patent marking plays a critical role in providing constructive notice to potential infringers and protecting a patent owner's ability to recover damages for infringement. Dive into this practice note...
The most robust due diligence disclosures are keyed to the company’s industry, stage of growth, and other particular circumstances. Pharmaceutical companies operate in a highly-regulated space, while development-stage companies in that industry face high costs of entry and often a lack of familiarity with the details of the approval process for their products. Use this template as a basis for getting the information you need from management to make all appropriate disclosures in the offering documents.
READ NOW »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+